VBLT - Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q3 2021 Results - Earnings Call Transcript

Vascular Biogenics Ltd. (VBLT) Q3 2021 Earnings Conference Call November 15, 2021 08:30 AM ET Company Participants Dror Harats - Chief Executive Officer Sam Backenroth - Chief Financial Officer Conference Call Participants Kevin DeGeeter - Oppenheimer Swayampakula Ramakanth - H.C. Wainwright Jonathan Aschoff - ROTH Capital Partners Jonathan Kreizman - Valore Research Presentation Operator Good morning and welcome to VBL Therapeutics Third Quarter 2021 Earnings Call. At this time, all participants are in a listen-only mode and please note that this conference is being recorded. A question and answer session will follow the formal presentation. [Operator Instructions] I would now turn the conference over to our host from VBL team. Please go ahead. Unidentified Company Representative Thank you. Good morning, everyone, and thank you for joining VBL Therapeutics third quarter 2021 financial results and corporate update call. Joining me on the call is Professor Dror Harats, Chief Executive Officer; and

For further details see:

Vascular Biogenics Ltd. (VBLT) CEO Dror Harats on Q3 2021 Results - Earnings Call Transcript